Treatment of osteoporosis
- PMID: 3306525
Treatment of osteoporosis
Abstract
In type I ("postmenopausal") osteoporosis, there is an excess loss of trabecular bone, resulting in fractures of the wrist and vertebrae. This type of osteoporosis occurs mainly in women 50 to 65 years of age. In either men or women over the age of 75 years, cortical and trabecular bone is lost, resulting in hip fractures; this is termed type II ("senile") osteoporosis. This article considers the treatment of established type I osteoporosis associated with vertebral fractures, the type of osteoporosis commonly encountered in clinical practice.
Similar articles
-
Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.Orthop Clin North Am. 1984 Oct;15(4):729-45. Orthop Clin North Am. 1984. PMID: 6493736
-
Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ. 1990 Aug 11;301(6747):314-8. doi: 10.1136/bmj.301.6747.314. BMJ. 1990. PMID: 2393738 Free PMC article.
-
[Current research in therapy of postmenopausal osteoporosis (author's transl)].Sem Hop. 1979 Feb 18-25;55(7-8):325-9. Sem Hop. 1979. PMID: 220722 Review. French.
-
[Drug therapy of osteoporosis].Orthopade. 1988 Sep;17(5):425-31. Orthopade. 1988. PMID: 3054714 Review. German.
-
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.CMAJ. 1996 Oct 1;155(7):962-5. CMAJ. 1996. PMID: 8837547 Free PMC article. Review.
Cited by
-
Total and regional bone mineral content in normal premenopausal women.Clin Rheumatol. 1991 Dec;10(4):423-5. doi: 10.1007/BF02206664. Clin Rheumatol. 1991. PMID: 1802499
-
Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.Osteoporos Int. 1993 Sep;3(5):255-60. doi: 10.1007/BF01623829. Osteoporos Int. 1993. PMID: 8400607
-
Sex differences in the acquisition of total bone mineral mass peak assessed through dual-energy X-ray absorptiometry.Calcif Tissue Int. 1992 Oct;51(4):251-4. doi: 10.1007/BF00334483. Calcif Tissue Int. 1992. PMID: 1422968
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical